AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Calithera BiosciencesMersana TherapeuticsLannettMagenta TherapeuticsCytomX Therapeutics
SymbolNASDAQ:CALANASDAQ:MRSNNYSE:LCINASDAQ:MGTANASDAQ:CTMX
Price Information
Current Price$5.71$21.17$7.49$9.40$8.06
52 Week RangeBuyBuyHoldBuyBuy
Beat the Market™ Rank
Overall Score1.81.81.61.41.6
Analysis Score4.51.53.03.34.4
Community Score2.82.72.72.12.8
Dividend Score0.00.00.00.00.0
Ownership Score1.04.01.01.01.0
Earnings & Valuation Score0.60.61.30.60.0
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyBuy
Consensus Price Target$8.50$20.25$14.00$19.00$13.56
% Upside from Price Target48.86% upside-4.35% downside86.92% upside102.13% upside68.18% upside
Trade Information
Market Cap$409.98 million$1.33 billion$308.68 million$349.04 million$406.88 million
Beta2.32.791.852.870.71
Average Volume737,9111,457,667727,359155,207551,498
Sales & Book Value
Annual Revenue$22.25 million$42.12 million$655.41 millionN/A$57.49 million
Price / Sales18.0829.630.46N/A6.44
CashflowN/AN/A$3.67 per shareN/AN/A
Price / CashN/AN/A2.04N/AN/A
Book Value$2.24 per share$1.64 per share$8.49 per share$3.62 per share$1.12 per share
Price / Book2.5512.910.88N/A7.20
Profitability
Net Income$-89,860,000.00$-28,210,000.00$-272,110,000.00$-76,770,000.00$-102,240,000.00
EPS($1.90)($0.65)$2.35($2.07)($2.26)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/A6.35N/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-6,099.64%-5.77%N/A-97.83%
Return on Equity (ROE)-68.38%-78.18%14.54%-53.94%-99.72%
Return on Assets (ROA)-57.43%-57.74%3.98%-48.30%-19.52%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.05%0.24%1.96%N/A0.35%
Current Ratio8.75%4.59%1.97%10.48%3.77%
Quick Ratio8.75%4.59%1.37%10.48%3.77%
Ownership Information
Institutional Ownership Percentage71.34%72.28%91.31%61.82%78.59%
Insider Ownership Percentage17.20%5.30%12.86%17.96%6.30%
Miscellaneous
Employees90861,02059137
Shares Outstanding70.44 million58.95 million40.35 million39.48 million45.92 million
Next Earnings Date8/13/2020 (Estimated)8/13/2020 (Estimated)8/25/2020 (Estimated)8/13/2020 (Estimated)8/5/2020 (Estimated)
OptionableOptionableNot OptionableOptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.